AXCELIS TECHNOLOGIES INC
ACLSNASDAQTrading Snapshot
- Day Range
- $128.29 – $130.87
- 52-Week Range
- $73.60 – $193.78
- Volume
- $4.44B
- Avg Volume
- $3.33B
- Shares Outstanding
- 30.7M
- Next Earnings
- Nov 16, 2026
Fundamentals Snapshot
- Annual Revenue
- $839M
- Last Q Revenue
- $215M
- P/E Ratio
- 41.3
- P/S Ratio
- 4.4x
- EPS (TTM)
- $3.01
- Dividend Yield
- 0.00%
- Dilution (1yr)
- −4.3%
Why Investors Own ACLS
- ✓High-growth profile — revenue up +20.0% YoY with expanding US Equity exposure.
- ✓Healthy economics — 74% gross margin and 8% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
AXCELIS TECHNOLOGIES INC
ACLS
StockOtter · stockotter.spaceAbout AXCELIS TECHNOLOGIES INC
Axcelis Technologies, Inc. is a company dedicated to the creation, production, and maintenance of specialized ion implantation and other essential processing machinery used in the fabrication of semiconductor chips. Operating internationally, its presence extends across North America, Europe, and Asia. The firm offers a wide array of implanter technologies, such as high-energy, high-current, and medium-current systems, designed to meet diverse application needs. Furthermore, Axcelis provides extensive post-sales support and lifecycle solutions, including the sale of pre-owned equipment, replacement parts, system upgrades, ongoing maintenance, and client instruction. It directly furnishes its advanced equipment and services to microchip manufacturers through its own dedicated sales personnel. Founded in 1978, Axcelis Technologies has its corporate headquarters situated in Beverly, Massachusetts.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Axcelis Announces Sponsorship and Participation in the 23rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026)
BEVERLY, Mass., Sept. 21, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be participating in the 23rd Intern
Axcelis Technologies (ACLS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Axcelis Technologies (ACLS) concluded the recent trading session at $103.75, signifying a -1.23% move from its prior day's close.
ACLS Falls 22.4% in Past Month as Recovery Meets Fresh Margin Pressure
Axcelis shares fell 22.4% in a month as recovering bookings and demand collide with weaker margins, backlog pressure and heavy China exposure.
ACLS Invests $35M in Korea To Expand Its Manufacturing Infrastructure
Axcelis plans a $35M South Korea ion implantation facility to expand Asian capacity as memory, power and mature-node activity improves.
Should Investors Buy ACLS as Growth Returns Despite Premium Valuation?
Axcelis growth is returning as memory, power and aftermarket demand improve, but premium valuation and incomplete margin recovery keep execution in focus.
Axcelis Announces Sponsorship and Participation in the 25th International Conference on Ion Implantation and Annealing Technology 2026
BEVERLY, Mass., Sept. 14, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be a Platinum Sponsor at the Intern